back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-05-11 14:56 Tx date 2022-05-11 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,260
+500 vol $4.52 each |
79,482 | |
| Filed 2022-03-17 15:29 Tx date 2022-03-16 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,961,218 vol |
15,796,540 | |
| Filed 2022-03-17 15:28 Tx date 2022-03-16 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,961,218 vol |
0 | |
| Filed 2021-07-06 19:41 Tx date 2021-06-29 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,035,178
+21,611,238 vol $0.0479 each |
41,132,615 | |
| Filed 2020-12-18 07:34 Tx date 2020-12-16 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+3,961,218 vol |
3,961,218 | |
| Filed 2020-12-18 07:32 Tx date 2018-05-01 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-27 13:06 Tx date 2020-11-26 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$34,090
+1,363,616 vol $0.025 each |
11,835,322 | |
| Filed 2020-04-02 17:59 Tx date 2020-03-30 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$837,166
+18,521,377 vol $0.0452 each |
19,521,377 | |
| Filed 2019-10-17 15:53 Tx date 2019-10-17 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,350
+130,000 vol $0.095 each |
10,471,706 | |
| Filed 2019-03-29 Tx date 2019-03-29 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,000,000
+5,128,206 vol $0.195 each |
10,341,706 | |
| Filed 2018-12-20 Tx date 2018-12-20 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,990
+100,000 vol $0.1199 each |
5,213,500 | |
| Filed 2018-12-17 Tx date 2018-12-17 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,315
+225,500 vol $0.13 each |
5,113,500 | |
| Filed 2018-08-29 Tx date 2018-08-28 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$115,199
+400,000 vol $0.288 each |
4,888,000 | |
| Filed 2018-08-28 Tx date 2018-08-24 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,035
+175,000 vol $0.2802 each |
4,264,000 | |
| Filed 2018-08-28 Tx date 2018-08-27 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$62,720
+224,000 vol $0.28 each |
4,488,000 | |
| Filed 2018-08-24 Tx date 2018-08-23 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80,621
+281,500 vol $0.2864 each |
4,089,000 | |
| Filed 2018-08-24 Tx date 2018-08-20 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,187
+186,500 vol $0.2691 each |
2,116,000 | |
| Filed 2018-08-24 Tx date 2018-08-21 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$217,499
+750,000 vol $0.29 each |
3,311,000 | |
| Filed 2018-08-24 Tx date 2018-08-21 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$125,222
+445,000 vol $0.2814 each |
2,561,000 | |
| Filed 2018-08-24 Tx date 2018-08-22 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$142,545
+496,500 vol $0.2871 each |
3,807,500 | |
| Filed 2018-08-20 Tx date 2018-08-16 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$230,157
+984,000 vol $0.2339 each |
1,160,000 | |
| Filed 2018-08-20 Tx date 2018-05-01 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-20 Tx date 2018-08-15 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
| Filed 2018-08-20 Tx date 2018-08-17 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$215,690
+769,500 vol $0.2803 each |
1,929,500 | |
| Filed 2018-08-20 Tx date 2018-08-15 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,720
+176,000 vol $0.22 each |
176,000 | |
| Filed 2018-08-20 Tx date 2018-05-01 |
$ASP
Acerus Pharmaceuticals Corporation |
Gudaitis, Edward Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|